Nashville, Tenn., (November 24, 2014) – Bass, Berry & Sims PLC has been recognized by The M&A Advisor for the firm’s work on behalf of AmSurg Corp. (NASDAQ: AMSG) in connection with its July 2014 acquisition of Sheridan Healthcare Inc.
Bass, Berry & Sims received the “M&A Deal of the Year” award in the “Healthcare/Life Sciences Deal of the Year (Over $250MM)” category as part of the 13th Annual M&A Advisor Awards. The Bass, Berry & Sims team was led by Chair of the firm’s Healthcare Practice Jim Jenkins and included a team of attorneys from various disciplines that coordinated and completed healthcare regulatory, corporate, real estate, benefits and labor due diligence; negotiated all related deal documents; and handled the related SEC filings required to be made by AmSurg. The firm also represented AmSurg in its common stock, preferred stock and senior notes offerings as well as entering into a new credit facility.
The M&A Advisor reported that more than 130 nominees, representing more than 600 companies, became finalists for this year’s awards. An independent judging committee of 11 top M&A experts determined the ultimate recipients of the awards. The awards were announced at the 13th Annual M&A Advisor Awards Gala on November 17 in New York, NY.
About The M&A Advisor
Since 1998, The M&A Advisor has been presenting, recognizing the achievement of and facilitating connections between the world’s leading mergers and acquisitions, financing and turnaround professionals with a comprehensive range of services, including M&A SUMMITS, M&A AWARDS, M&A CONNECTS™, M&A LINKS™, MandA.TV and M&A MARKET INTEL™. For more information, please visit www.maadvisor.com.
About Bass, Berry & Sims PLC
With more than 200 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims has been involved in some of the largest and most significant litigation matters and business transactions in the country. For more information, visit bassberry2022.wpengine.com.